Ausgabe 2/2014
Inhalt (8 Artikel)
A Review of Safety-Related Pregnancy Data Surrounding the Oral Disease-Modifying Drugs for Multiple Sclerosis
Ellen Lu, Bing Wei Wang, Sura Alwan, Anne Synnes, Leanne Dahlgren, A. Dessa Sadovnick, Helen Tremlett
Potential Role of N-Acetylcysteine in the Management of Substance Use Disorders
Erin A. McClure, Cassandra D. Gipson, Robert J. Malcolm, Peter W. Kalivas, Kevin M. Gray
Combined Pharmacotherapies for the Management of Alcoholism: Rationale and Evidence to Date
Mary R. Lee, Lorenzo Leggio
Attention-Deficit/Hyperactivity Disorder with Inadequate Response to Stimulants: Approaches to Management
Ann C. Childress, Floyd R. Sallee
Neurological and Psychiatric Adverse Effects of Antiretroviral Drugs
Michael S. Abers, Wayne X. Shandera, Joseph S. Kass
Clinical Relevance of Brain Volume Measures in Multiple Sclerosis
Nicola De Stefano, Laura Airas, Nikolaos Grigoriadis, Heinrich P. Mattle, Jonathan O’Riordan, Celia Oreja-Guevara, Finn Sellebjerg, Bruno Stankoff, Agata Walczak, Heinz Wiendl, Bernd C. Kieseier
A 2-Year Prospective Cohort Study of Antidementia Drug Non-Persistency in Mild-to-Moderate Alzheimer's Disease in Europe
Virginie Gardette, Maryse Lapeyre-Mestre, Antoine Piau, Adeline Gallini, Christelle Cantet, Jean-Louis Montastruc, Bruno Vellas, Sandrine Andrieu
Aripiprazole: A Review of Its Use in the Treatment of Manic Episodes in Adolescents with Bipolar I Disorder
Kate McKeage